114809-55-1

Upstream product

• 821-11-4 1,4-butenediol 
• 824-94-2 p-methoxybenzyl chloride 
• 2746-25-0 p-Methoxybenzyl bromide 

Downstream Products

• 114809-59-5 6-<<1,4-bis<(4-methoxybenzyl)oxy>but-2-oxy>amino>-4-chloro-2,5-diformamidopyrimidine 
• 114778-93-7 9-<1,4-bis<(4-methoxybenzyl)oxy>but-2-oxy>-6-chloro-2-formamidopurine 
• 114809-60-8 2-amino-9-<1,4-bis<(4-methoxybenzyl)oxy>but-2-oxy>-6-chloropurine 
• 131068-38-7 N-<1,4-bis<(4-methoxybenzyl)oxy>but-2-oxy>phthalimide 
• 114809-58-4 1,4-bis<(4-methoxybenzyl)oxy>but-2-oxyamine 
• 329188-99-0 1-[(2E,9E)-(4R,5R,6S,8S)-6,11-Bis-(tert-butyl-dimethyl-silanyloxy)-4-methoxy-8-(2-methoxy-ethoxymethoxy)-3,5,9-trimethyl-undeca-2,9-dienyloxymethyl]-4-methoxy-benzene 
• 1026332-49-9 (2E,9E,5S,6S,8S,4R)-4-methoxy-8-[(2-methoxyethoxy)methoxy]-1-[(4-methoxyphenyl)methoxy]-3,5,9-trimethyl-11-(1,1,2,2-tetramethyl-1-silapropoxy)undeca-2,9-dien-6-ol 
• 329188-97-8 (2E,9E)-(4R,5R,8S)-8,11-Bis-(tert-butyl-dimethyl-silanyloxy)-4-methoxy-1-(4-methoxy-benzyloxy)-3,5,9-trimethyl-undeca-2,9-dien-6-one 
• 329188-98-9 (2E,9E,8S,4R,5R)-4-methoxy-8-[(2-methoxyethoxy)methoxy]-1-[(4-methoxyphenyl)methoxy]-3,5,9-trimethyl-11-(1,1,2,2-tetramethyl-1-silapropoxy)undeca-2,9-dien-6-one 
• 329189-00-6 (2E,9E)-(4S,6S,7R,8R)-6-(tert-Butyl-dimethyl-silanyloxy)-8-methoxy-11-(4-methoxy-benzyloxy)-4-(2-methoxy-ethoxymethoxy)-3,7,9-trimethyl-undeca-2,9-dienal 
• 329188-96-7 1-({[(2E)-4,4-dimethoxy-3-methylbut-2-en-1-yl]oxy}methyl)-4-methoxybenzene 
• 197227-70-6 (2E)-4-[(4-methoxybenzyl)oxy]-2-methylbut-2-enal 
• 121289-23-4 p-methoxybenzyloxyacetaldehyde 

Relevant academic research and scientific papers

METHOD FOR THE SYNTHESIS OF 4-ALKOXY-, 4-HYDROXY- AND 4-ARYLOXY-SUBSTITUTED TETRAHYDRO-FURO[3,4-B]FURAN-2(3H)-ONE COMPOUNDS

The present invention relates to a method for the synthesis of enantiomerically and diastereomerically enriched 4-alkoxy-, 4-hydroxy- or 4-aryloxy- substituted tetrahydro-furo[3,4-b]furan-2(3H)-ones by aldol coupling of a suitable hydroxyl-protected hydro

HEPATITIS C VIRUS INHIBITORS

The present invention relates to new compounds useful for the treatment or prevention of hepatitis C, process for preparing them, and a composition for the treatment or prevention of hepatitis C comprising the compounds as an active ingredient.

Synthesis and Antiviral Activity of 9-Alkoxypurines. 2. 9-(2,3-Dihydroxypropoxy)-, 9-(3,4-Dihydroxybutoxy)-, and 9-(1,4-Dihydroxybut-2-oxy)purines

Reaction of alkenoxyamines (3, 5) or (R,S)-, (R)-, and (S)-hydroxy-protected derivatives of hydroxyalkoxyamines (20a,b, 37a-c) with 4,6-dichloro-2,5-diformamidopyrimidine (4) and cyclization of the resultant 6-- and 6-(alkoxyamino)pyrimid